RAHWAY, N.J. - Merck is officially adding an experimental flu prevention drug to its portfolio. The New Jersey-based pharmaceutical giant has completed its $9.2 billion acquisition of Cidara ...

Merck Group, the German pharmaceutical company, saw its Frankfurt-listed shares fall 10% on Tuesday morning after the company said it had decided to call off a Phase III trial of its cancer drug ...

Merck (MRK) is back in focus after a trio of recent developments, including an upcoming J.P. Morgan Healthcare Conference fireside chat, encouraging KEYTRUDA ovarian cancer trial results, and a ...

Add Yahoo as a preferred source to see more of our stories on Google. The logo of the pharmaceutical and chemical company Merck is displayed on flags on a building at its headquarters in Darmstadt.

HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fastest growing cell culture segment; hold potential to ...

US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of ...

Belen Garijo, Chair Executive Board and CEO, Merck Group, on the tremendous opportunity in India and AI.

・As per Reuters, both the drugs have multibillion-dollar potential. ・FDA expects Merck to submit its applications for Enlicitide in April and for Sac-TMT in October or November next year. ・Other drugs ...

Aug 1 (Reuters) - Merck KGaA (MRCG.DE), opens new tab is seeing a faster-than-expected improvement in its semiconductor materials business and is aiming to accelerate its drug development pipeline, ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human ...

Article ‘Count’ and ‘Share’ for Merck Group based on listed parameters only. The articles listed below published by authors from Merck Group, organized by journal and article, represent the research ...